This module covers the critical paradigm shifts in the management of Type 1 Diabetes (T1D) for both adults and children. These guidelines replace the previous 2018 chapters on Glycemic Management in Adults and portions of the Type 1 Diabetes in Children and Adolescents chapter.
Key Concepts Covered in These Flashcards:
Unified Glycemic Targets: The shift to an A1C target of <7.0% for all ages, including children, to protect brain development and reduce long-term complications.
Technology First: The new recommendation establishing Automated Insulin Delivery (AID) systems as the preferred treatment method for all individuals willing and able to use them.
Advanced Therapeutics: The role of ultrarapid and ultra-long-acting insulin analogues in minimizing hypoglycemia and improving Time in Range (TIR).
Adjunctive Therapies: Evidence-based guidance on the use of non-insulin agents like Metformin, GLP-1RAs, and SGLT2 inhibitors in adults.
Emergency Management: Updated protocols for treating hypoglycemia (including adjustments for AID users) and managing Diabetic Ketoacidosis (DKA) with fluids and subcutaneous insulin.